Skip to main content
. 2018 Mar 7;2018:4248971. doi: 10.1155/2018/4248971

Table 3.

Comparison of KRAS gene mutation in ctDNA and tumor tissue.

Plasma Synchronous group tumor Metachronous group tumor Total Sensitivity (%) Specificity (%) Concordance (%)
Mt Wt NA Mt Wt NA
Mt 4 2 1 12 2 2 23 66.67% 90.00% 81.25%
Wt 2 14 5 6 22 4 53
Total 6 16 6 18 24 6 76

Note. Mt, mutate type; Wt, wild type; NA, not available.